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ABSTRACT 16 
Cytosolic recognition of DNA has emerged as a critical cellular mechanism of host immune 17 
activation upon pathogen invasion. The central cytosolic DNA sensor cGAS activates STING, 18 
which is phosphorylated, dimerises and translocates from the ER to a perinuclear region to 19 
mediate IRF-3 activation. Poxviruses are dsDNA viruses replicating in the cytosol and hence likely 20 
to trigger cytosolic DNA sensing. Here we investigated the activation of innate immune signalling 21 
by 4 different strains of the prototypic poxvirus vaccinia virus (VACV) in a cell line proficient in DNA 22 
sensing. Infection with the attenuated VACV strain MVA activated IRF-3 via cGAS and STING, and 23 
accordingly STING dimerised and was phosphorylated during MVA infection. Conversely, VACV 24 
strains Copenhagen and Western Reserve inhibited STING dimerisation and phosphorylation 25 
during infection and in response to transfected DNA and cGAMP, thus efficiently suppressing DNA 26 
sensing and IRF-3 activation. A VACV deletion mutant lacking protein C16, thought to be the only 27 
viral DNA sensing inhibitor acting upstream of STING, retained the ability to block STING 28 
activation. Similar inhibition of DNA-induced STING activation was also observed for cowpox and 29 
ectromelia viruses. Our data demonstrate that virulent poxviruses possess mechanisms for 30 
targeting DNA sensing at the level of the cGAS-STING axis and that these mechanisms do not 31 
operate in replication-defective strains such as MVA. These findings shed light on the role of 32 
cellular DNA sensing in poxvirus-host interactions and will open new avenues to determine its 33 
impact on VACV immunogenicity and virulence. 34 
 35 
IMPORTANCE 36 
Poxviruses are dsDNA viruses infecting a wide range of vertebrates and include the causative 37 
agent of smallpox (variola virus) and its vaccine vaccinia virus (VACV). Despite smallpox 38 
eradication VACV remains of interest as a therapeutic. Attenuated strains are popular vaccine 39 
candidates, whereas replication-competent strains are emerging as efficient oncolytics in 40 
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virotherapy. The successful therapeutic use of VACV depends on a detailed understanding of its 41 
ability to modulate host innate immune responses. DNA sensing is a critical cellular mechanism for 42 
pathogen detection and activation of innate immunity that is centrally coordinated by the ER-43 
resident protein STING. Here STING is shown to mediate immune activation in response to MVA, 44 
but not to virulent VACV strains or other virulent poxviruses, which prevent STING activation and 45 
DNA sensing during infection and after DNA transfection. These results provide new insights into 46 
poxvirus immune evasion and have implications in the rational design of VACV-based therapeutics.  47 
 48 
  49 
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INTRODUCTION 50 
Cells sense the presence of invading pathogens by the use of pattern-recognition receptors 51 
(PRRs), a set of germ-line encoded molecules recognising pathogen-associated molecular 52 
patterns (PAMPs). Nucleic acids derived from viral infection are potent PAMPs that can be 53 
recognised in the cell cytosol and the endolysosomal compartment by dedicated PRRs. 54 
Recognition of RNA or DNA leads to the secretion of type I interferon (IFN) and other inflammatory 55 
cytokines and the expression of IFN-stimulated genes (ISGs), which restrict viral replication. 56 
Cytosolic dsRNA is sensed by retinoic acid-inducible gene (RIG)-I and melanoma differentiation-57 
associated gene (MDA)-5. Both RIG-I and MDA-5 associate with the IFN-β promoter stimulator 58 
(IPS)-1 (also known as MAVS), a protein residing in the mitochondrion that mediates the activation 59 
of IFN responsive factors (IRFs) and nuclear factor κ-light-chain-enhancer of activated B cells (NF-60 
κB) (1). Cytosolic dsDNA can be sensed by multiple PRRs, the importance of which is largely 61 
dependent on the cell type (1). A critical sensor is the cyclic GMP-AMP synthase (cGAS), a 62 
nucleotidyltransferase that generates cyclic GMP-AMP (cGAMP) upon binding to dsDNA (2-4). 63 
cGAMP acts as a secondary messenger and docks on stimulator of interferon genes (STING) 64 
inducing conformational changes and STING self-association. Upon cGAMP binding STING is 65 
phosphorylated and activated and acts as a scaffold for the recruitment of TANK-binding kinase 66 
(TBK)-1 and the downstream activation of IRFs and NF-κB (5-8). Besides cGAS, other molecules 67 
have been proposed to recognise cytosolic DNA and contribute to STING-dependent IFN 68 
responses, including DAI (9), IFI16 (10), the DExD/H-box helicases DHX9, DDX36 (11) and DDX41 69 
(12); and the DNA-damage proteins Ku70/80 (13), DNA-PK (14) and Mre11 (15). Whether and how 70 
these molecules impact the cGAS-cGAMP-STING axis and whether they show pathogen and/or 71 
cell type specificity are important questions in the field (16, 17). 72 
 73 
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Poxviruses are a highly successful family of viruses infecting a broad range of species. Besides 74 
vaccinia virus (VACV), the prototypic member of the family, and the virus that was used to 75 
eradicate smallpox, there are other poxviruses that can cause disease in humans (e.g. the 76 
monkeypox virus or the cowpox virus [CPXV]), or in animals (e.g. the rabbit myxoma virus or the 77 
mouse ectromelia virus [ECTV]). In addition to virulent strains, non-virulent strains also exist and 78 
are popular candidates as recombinant vaccine vectors. Modified vaccinia Ankara (MVA) is an 79 
attenuated VACV strain generated through more than 500 serial passages in chicken cells. 80 
Through that serial passaging MVA lost its ability to replicate in human cells due to severe 81 
deletions and truncations affecting expression of multiple genes compared to the reference strains 82 
Copenhagen (COP) or Western Reserve (WR) (18, 19). Accordingly, and in contrast to COP or 83 
WR, which retain full inhibitory capacity, MVA has been shown to trigger innate immune activation 84 
in multiple experimental settings. 85 
 86 
Poxviruses contain large dsDNA genomes of about 200 kbp with a coding capacity for more than 87 
200 proteins. Poxviruses are unique in being the only dsDNA viruses to replicate exclusively in the 88 
cell cytoplasm. Replication in this compartment, however, makes this family of viruses particularly 89 
susceptible to detection by cytosolic DNA sensors. The success of poxviruses therefore implies the 90 
evolution of countermeasures to either avoid recognition or to dampen DNA sensing-induced 91 
innate immune activation. An example of such countermeasures is protein C16 which targets DNA-92 
PK and inhibits IRF-3 activation in response to DNA (20). C16 contributes to virulence and is 93 
conserved in most VACV strains and poxviruses including variola virus (VARV), but is non-94 
functional in MVA (20, 21). Besides C16, VACV encodes a vast array of immunomodulatory 95 
proteins able to inhibit the activation of the IRFs and NF-κB transcription factors (22). Some of 96 
these proteins exert their inhibitory action downstream of STING at the level of TBK-1 (23, 24) or 97 
IRF-3 (25) and can potentially block STING-mediated induction of type I IFN. However, no VACV 98 
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proteins have been reported to specifically target the cGAS-cGAMP-STING axis. To seek evidence 99 
for such inhibitors, we investigated the differential capacity of 4 VACV strains to inhibit innate 100 
immunity and STING activation in a human monocytic cell line in response to DNA sensing. We 101 
demonstrate that virulent VACV strains, as well as CPXV and ECTV, but not the non-virulent strain 102 
MVA, encode factors preventing STING phosphorylation and dimerisation during viral infection and 103 
upon transfection with exogenous DNA. These findings uncover a novel immune evasion strategy 104 
in poxviruses and highlight the importance of DNA sensing in the innate anti-viral defence.  105 
 106 
RESULTS 107 
PMA-differentiated THP-1 cells activate IRF-3 in response to MVA, but not COP or WR, 108 
infection. To assess the capacity of VACV strains to modulate cellular innate immunity, we sought 109 
a cell line that (i) responds to PAMPs; (ii) provides consistent and high-throughput quantitative 110 
measurements; and (iii) is amenable to genetic manipulation. THP-1 monocytes expressing 111 
Gaussia luciferase (GLuc) under control of the promoter of the IRF-3-dependent gene IFIT-1 (26) 112 
provided those characteristics. We differentiated these cells with phorbol 12-myristate 13-acetate 113 
(PMA) for 48 h and infected them with 3 different VACV strains at several plaque forming units 114 
(PFU) per cell. We monitored GLuc activity over a period of 24 h and plotted it as a fold increase 115 
over mock-infected cells. MVA infection triggered IFIT-1-driven GLuc activity and this was 116 
quantitated 24 h post-infection (p.i.) at approximately 25-, 20-, and 15-fold increase after infection 117 
with 2, 1 and 0.5 PFU/cell, respectively (Fig. 1A). Infection with a higher PFU/cell did not show 118 
higher levels of activation (data not shown) possibly due to MVA-induced apoptosis (27, 28). 119 
Conversely, infection with VACV strains COP and WR did not induce GLuc activity. To confirm that 120 
these differences were not caused by variations in virus titer, the same sucrose purified stocks 121 
were used to infect permissive BHK-21 cells with 5 and 2 PFU/cell. Twelve h p.i. the cells were 122 
lysed and lysates were subjected to SDS-PAGE. Immunoblotting against the late viral protein D8 123 
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confirmed that infection levels were similar across the different strains (Fig. 1B). We then repeated 124 
the infection of THP-1 cells with 2 PFU/cell and measured the induction of CXCL10 and IFN-β 125 
mRNA by quantitative PCR 24 h p.i. MVA infection triggered CXCL10 expression, whereas COP 126 
and WR infections did not (Fig. 1C). Production of CXCL10 was subsequently confirmed by ELISA 127 
(Fig. 1D). Similarly, we detected a significant increase in IFN-β mRNA expression in response to 128 
MVA, but not COP or WR, infection (Fig. 1E). The presence of active IFN-β in the MVA-infected 129 
medium was confirmed in a bioassay on HEK293T cells transfected with a reporter expressing 130 
luciferase under the control of the IFN-stimulated response element (ISRE). Supernatants from 131 
MVA-infected THP-1 cells induced a statistically significant increase in ISRE activity in the 132 
HEK293T cells in a dose-dependent manner (Fig. 1F). Form these data we concluded that MVA 133 
induces a robust innate immune response in THP-1-IFIT-1-GLuc cells that is not observed with 134 
COP or WR, and that measurements of GLuc activity correlate with the upregulation of antiviral 135 
cytokines including type I IFN. 136 
 137 
IRF-3 activation in response to MVA infection requires the cGAS-STING axis. VACV is a 138 
dsDNA virus that replicates in the cell cytoplasm and therefore has the potential to be detected by 139 
cytosolic DNA sensing mechanisms, in which STING has a pivotal role. To determine whether 140 
STING had an impact on the IRF-3 response induced by VACV in THP-1 cells, we transduced 141 
THP-1-IFIT-1-GLuc cells with a lentivirus expressing shRNA against cellular STING, or a control 142 
shRNA, and selected them with puromycin. Control and shSTING cells were PMA-differentiated 143 
and STING levels assessed by immunoblotting. shSTING cells showed reduction in STING 144 
expression compared to control cells (Fig. 2A). Furthermore, cells were exposed to cytosolic DNA 145 
(herring testes [HT]-DNA transfection) or RNA (Sendai virus [SeV] infection) and IRF-3 responses 146 
were determined by luciferase activity. shSTING cells had a significantly impaired response to HT-147 
DNA transfection compared to control cells, but both cell lines responded equally to SeV infection 148 
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which activates IRF-3 via RNA sensors (Fig. 2B). We next measured the response to VACV 149 
infection in the STING-depleted cells. Differentiated cells were challenged with MVA at various 150 
PFU/cell and luciferase activity was measured 24 h p.i. MVA infection triggered IFIT-1-driven GLuc 151 
expression in a dose-dependent manner, and this was impaired in shSTING cells in a statistically 152 
significant manner (Fig. 2C).  153 
 154 
To further confirm that MVA-induced activation of IRF-3 in THP-1 cells derived from DNA sensing, 155 
we generated a THP-1 cell line expressing shRNA against cGAS, the main cellular DNA sensor. 156 
Immunoblotting for cGAS confirmed cGAS depletion in shcGAS cells compared to control cells 157 
(Fig. 2D). Accordingly, shcGAS cells failed to induce IFIT-1-GLuc expression in response to HT-158 
DNA transfection whilst their response to the RNA sensing activator SeV was unaffected (Fig. 2E). 159 
Similar to the results obtained in cells depleted for STING, MVA infection triggered a significantly 160 
reduced response in cells depleted for cGAS (Fig. 2F). Together these results demonstrate that 161 
cGAS and STING contribute to IRF-3 activation in THP-1 cells infected with MVA. 162 
 163 
COP and WR suppress IRF-3 activation induced by exogenous DNA. The absence of IRF-3 164 
activation upon COP or WR infection could be explained by (i) an ability of these viruses to mask 165 
their dsDNA genome in a manner that is lost in MVA, or (ii) the production of viral factors that 166 
prevent IRF-3 activation. We addressed the presence of viral factors by determining the capacity of 167 
all 3 VACV strains to inhibit IRF-3 activation mediated by exogenous DNA. First, PMA-168 
differentiated THP-1 cells were infected with 2 PFU/cell of MVA, COP and WR for 6 h and 169 
subsequently transfected with HT-DNA. After 16 h HT-DNA transfection induced a ~30 fold 170 
increase in IFIT-1-driven GLuc activity in mock-infected and MVA-infected cells, and this was 171 
completely suppressed in COP-infected and WR-infected cells (Fig. 3A). We then repeated the 172 
infection and measured CXCL10 and IFN-β mRNA expression 6 h after HT-DNA transfection. DNA 173 
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challenge triggered expression of CXCL10 (Fig. 3B) and IFN-β (Fig. 3C) in mock-infected cells and 174 
this was similar to that observed in MVA-infected cells. COP and WR infections inhibited the DNA-175 
induced expression of both cytokines in a statistically significant manner. Therefore, COP and WR 176 
efficiently abolish IRF-3 activation in response to exogenous DNA in THP-1 cells, most likely by the 177 
expression of viral factors that are lost or defective in MVA. 178 
 179 
COP and WR inhibit STING phosphorylation in response to DNA. The ability of VACV virulent 180 
strains to block DNA-induced IRF-3 signalling could be ascribed to a cumulative effect of viral 181 
inhibitors acting on the IRF-3 pathway, but also to the presence of specific inhibitors acting at the 182 
level of cGAS/STING. To address the latter we examined DNA-induced STING activation in VACV-183 
infected cells. A hallmark of STING activation is the phosphorylation of Ser366, an event associated 184 
with IRF-3 recruitment and activation (6). We infected PMA-differentiated THP-1 cells with COP or 185 
WR for 6 h and subsequently transfected the cells with HT-DNA. Whole-cell lysates were subjected 186 
to immunoblotting against p-STING Ser366 at 2, 4 and 6 h after DNA transfection. In mock-infected 187 
cells, p-STING was detected at 2 h and was prominent at 4 and 6 h post-transfection concomitant 188 
with p-IRF-3 induction (Fig. 4A). In infected cells, however, p-STING levels were significantly 189 
reduced, particularly after WR infection, and this correlated with a reduction in p-IRF-3. 190 
Immunoblotting against viral protein D8 revealed that the infection levels between COP and WR 191 
were similar. Phosphorylated and total STING levels from 3 independent experiments using WR 192 
were quantitated and the reduction of p-STING upon DNA challenge was shown to be statistically 193 
significant (Fig. 4B).  194 
 195 
COP and WR inhibit STING dimerisation. To further assess whether WR and COP suppress 196 
STING activation, we examined the ability of these viruses to block STING dimerisation in 197 
response to DNA (6, 7, 29). Cells were infected with MVA, COP or WR at 2 PFU/cell and 198 
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subsequently transfected with HT-DNA for a further 4 h. Cells were lysed and treated to preserve 199 
endogenous STING dimers and these were assessed by immunoblotting. In non-stimulated, mock-200 
infected cells a band at ~80 kDa corresponding to the expected size of a STING dimer was 201 
detected and became more intense upon DNA sensing stimulation, consistent with the formation of 202 
STING dimers in response to exogenous DNA (Fig. 5A). DNA-induced STING dimerisation in MVA-203 
infected cells was indistinguishable from that in mock-infected cells, highlighting the inability of 204 
MVA to block STING activation. This notion was also supported by measuring p-STING levels. 205 
Conversely, cells infected with COP or WR showed a reduction in DNA-induced STING 206 
dimerisation. In agreement with previous observations, p-STING levels were also efficiently 207 
suppressed by COP and WR. Levels of viral D8 confirmed similar infectivity between COP and 208 
WR. D8 could not be detected in MVA-infected cell lysates due to the fact that MVA does not 209 
express late proteins in THP-1 cells. We then repeated this experiment and quantitated the dimeric 210 
and monomeric STING bands upon WR infection and DNA stimulation. The results confirmed that 211 
WR infection inhibited STING dimerisation in a statistically significant manner (Fig. 5B). Finally, we 212 
assessed STING dimerisation and stability upon WR infection at multiple PFU/cell. Infection with as 213 
little as 1 PFU/cell was sufficient to prevent DNA-induced STING dimerisation (Fig. 5C). Infection 214 
with a higher PFU/cell did not affect the levels of monomeric STING, which remained largely 215 
constant and close to those seen in unstimulated cells. Similar data were obtained with COP (Fig. 216 
5D). This suggests that VACV does not affect STING stability. Taken together these data 217 
demonstrate for the first time that VACV prevents STING phosphorylation and dimerisation in 218 
response to DNA.  219 
 220 
VACV deletion mutant vv811 inhibits STING activation. VACV protein C16 is expressed by 221 
COP and WR and targets DNA-PK (20), a cytosolic DNA sensor recognising VACV and acting via 222 
STING (14, 30). To determine whether C16 was responsible for the observed STING inhibition, we 223 
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took advantage of vv811, a VACV deletion mutant deriving from COP that lacks 55 open reading 224 
frames (ORFs) including C16L (31, 32). Contrary to COP, infection with vv811 triggered ~7 fold 225 
increase in IFIT-1-driven GLuc activity (Fig. 6A), suggesting that the absence of 226 
immunomodulatory genes limits the ability of vv811 to block IRF-3 responses in differentiated THP-227 
1 cells. vv811 infection reduced the levels of IRF-3 activation observed after DNA transfection as 228 
compared to mock-infected cells and this was statistically significant (Fig. 6A). However, vv811 did 229 
not reduce IRF-3 activation as effectively as COP, but rather to the levels induced by vv811 230 
infection in the absence of DNA stimulation, suggesting that this baseline activation on infection 231 
may be induced by a response that is unrelated to DNA sensing. vv811 inhibition of DNA-induced 232 
IRF-3 activation was also observed on measurement of CXCL10 (Fig. 6B) and IFN-β (Fig. 6C) 233 
mRNA expression. We then assessed the kinetics of activation of p-STING after HT-DNA 234 
transfection in cells infected with vv811 (Fig. 6D). As shown previously, mock-infected cells showed 235 
substantial levels of p-STING at 4 and 6 h post-stimulation and these correlated with p-IRF-3 236 
levels. The kinetics of DNA-induced p-STING formation in MVA-infected cells was indistinguishable 237 
from that observed in mock-infected cells, implying that no inhibitors of DNA sensing are expressed 238 
in MVA. Indeed low levels of p-STING could be detected after MVA infection in the absence of 239 
exogenous DNA transfection, indicating that MVA infection is sufficient to trigger STING activation. 240 
In contrast, vv811 infection efficiently suppressed both p-STING and p-IRF-3. As expected, viral D8 241 
could not be detected in MVA-infected cells due to its late expression, but was detected in vv811-242 
infected cells demonstrating that this virus replicates in THP-1 cells despite its multiple deletions. 243 
Thus, it appears that VACV expresses mechanisms, other than C16, to prevent STING activation 244 
in response to DNA sensing.  245 
 246 
VACV inhibits STING activation in response to cGAMP. To gain further insight into VACV 247 
inhibition of STING-dependent DNA sensing signalling, we assessed the inhibitory capacity of the 248 
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different VACV strains in response to cGAMP. Exposure to cGAMP triggered ~6-fold increase in 249 
IRF-3-driven reporter activity in PMA-differentiated THP-1 cells (Fig. 7A). This activation was 250 
significanty suppressed in cells that had been previously been infected with vv811, COP or WR. 251 
Infection with MVA triggered reporter activity on its own and this activity was even enhanced after 252 
exposure to cGAMP. To further demonstrate that cGAMP activated STING and this was 253 
suppressed by VACV inhibitory strains, we assessed STING dimerisation in response to cGAMP. 254 
Exposure to cGAMP induced the formation of STING dimers in mock-infected cells, but these were 255 
inhibited in cells infected with WR and even with the deletion mutant vv811 (Fig. 7B). Therefore, 256 
irrespective of the potential ability to interfere with cGAS and/or its enzymatic activity, VACV 257 
efficiently antagonises the action of STING. 258 
 259 
Cowpox and Ectromelia virus prevent STING activation. To determine whether inhibition of 260 
STING activation is unique to VACV or occurs after infection with other poxviruses, we studied 261 
CPXV and ECTV. Cells were infected with 2 PFU/cell of CPXV reference strain Brighton Red and 262 
ECTV reference strain Moscow as well as WR as a control for 6 h, and subsequently stimulated by 263 
DNA transfection for a further 4 h. Levels of STING dimerisation were assessed by immunoblotting 264 
and viral infection was confirmed by detecting D8 (Fig. 7). As expected, uninfected cells stimulated 265 
with DNA showed elevated levels of STING dimers, and these were absent in WR-infected cells. 266 
Infection with CPXV and ECTV strains also inhibited STING dimerisation to the same extent as 267 
WR, indicating that inhibition of STING activation is conserved amongst multiple orthopoxviruses. 268 
 269 
DISCUSSION 270 
STING has emerged as a pivotal molecule in the integration of signals deriving from various 271 
cytosolic DNA sensors and in particular cGAS. Upon binding cGAMP STING dimerises, 272 
translocates to perinuclear structures and is phosphorylated (5-8). This promotes the 273 
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phosphorylation and activation of IRF-3 and the subsequent production of type I IFN and 274 
inflammatory cytokines. Whether and how VACV has evolved mechanisms counteracting the 275 
cGAS-STING axis is currently unknown. Here we provide evidence demonstrating that VACV 276 
inhibits the phosphorylation and dimerisation of STING in response to DNA and cGAMP (Fig. 4, 5 277 
and 7). These observations correlated with the inhibition of IRF-3 activation and of the expression 278 
of IFN-β and CXCL10 cytokines (Fig. 1 and 3). Inhibition of STING activation occurred after 279 
infection with strains COP and WR, but not MVA. MVA is an attenuated VACV strain unable to 280 
replicate and express late genes in most mammalian cell types including human cells. For this 281 
reason it is typically titrated on chicken cells (i.e. chicken embryo fibroblasts [CEF]) as opposed to 282 
virulent VACV strains which can be titrated on conventional mammalian cell lines (e.g. BS-C-1). 283 
Because of this discrepancy we infected permissive BHK-21 cells (in which MVA is fully replicative 284 
and hence the late viral protein D8 is expressed) in parallel to differentiated THP-1 cells and 285 
observed similar levels of infectivity across the 3 VACV strains (Fig. 1). In PMA-differentiated THP-286 
1 cells MVA infection was sufficient to trigger IRF-3 activation (Fig. 1) and this activation required 287 
cGAS and STING (Fig. 2). This data is in line with the reported role of cGAS upon MVA infection in 288 
murine dendritic cells (33). MVA is a VACV strain sharing the same dsDNA PAMP as COP or WR 289 
but containing up to 6 major genomic deletions (18). A likely explanation for the inability of MVA to 290 
block STING activation is that MVA does not express the viral gene(s) responsible for STING 291 
inhibition, which are present in COP and WR. However, the possibility existed that the COP and 292 
WR genomes were immunologically weaker PAMPs than that of MVA, or that COP and WR were 293 
able to mask their genomes more efficiently. Although these possibilities cannot formally be ruled 294 
out, the observation that COP and WR blocked STING activation in response to transfected DNA 295 
or cGAMP exposure (Fig. 4 and 7) argues that virulent VACV strains express one or multiple 296 
factors that are capable of acting in trans to block STING activation induced by the viral genome as 297 
well as exogenous DNA. These factors may not operate in MVA, but they (or functionally 298 
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equivalent products) must be present in CPXV and ECTV, and presumably in other virulent 299 
poxviruses, because both ECTV and CPXV inhibited STING activation to the same extent as 300 
VACV (Fig. 8). 301 
 302 
There are 29 genes absent in MVA due to large genomic deletions and truncations. In addition, 303 
MVA contains non-functional copies of genes due to point mutations and small truncations 304 
acquired during serial passage in chicken cells and does not express late genes due its inability to 305 
complete the viral cycle in most mammalian cells (19, 34, 35). Therefore a large number of VACV 306 
proteins could account for the inhibition of STING activation reported here. An obvious candidate is 307 
protein C16, the viral inhibitor of DNA-PK, which is absent in MVA, but conserved across VACV 308 
replicative strains as well as in CPXV and ECTV (21). Hence we assessed DNA-induced STING 309 
activation during vv811 infection, a VACV deletion mutant that contains 2 large deletions in the 310 
genome terminal regions and does not encode C16 (31). vv811 infection was sufficient to trigger 311 
intermediate levels of IRF-3 activation, consistent with the loss of multiple immune modulators 312 
encoded by the missing genome fragments. Despite this reduced inhibitory capacity, vv811 was as 313 
effective as fully virulent VACV strains in preventing DNA-induced STING activation (Fig. 6). This 314 
indicates that neither C16 nor any of the other 54 ORFs missing in vv811 is required for the 315 
observed STING inhibition, and that additional mechanisms must exist and cooperate with C16 to 316 
effectively block DNA sensing in multiple contexts. Identification of the viral mechanism(s) may thus 317 
require a combination of genetic and biochemical approaches and will be the subject of future 318 
studies.  319 
 320 
Whatever the exact mechanism is, it will add to the inhibitory capacity provided by other VACV 321 
factors targeting the IRF-3 signaling cascade downstream of cGAS/STING such as proteins C6 322 
and K7, which act at the level of TBK-1 (23, 24), or protein N2, which blocks IRF-3 activity in the 323 
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nucleus (25). VACV redundancy in targeting cellular functions is common and also occurs to 324 
prevent NF-κB activation (22) or cell death (36). In the case of NF-κB, vv811 has been shown to 325 
inhibit NF-κB activation to the same extent as its parental strain COP despite its large genome 326 
deletions (37), and even a recombinant vv811 engineered to lack all described NF-κB inhibitors 327 
retained a similar inhibitory capacity as the original vv811, revealing the existence of additional, yet 328 
uncharacterised inhibitors (38-40). This remarkable redundancy is necessary to counteract the 329 
complex signaling and cross-talk governing innate immune responses in vivo, and indicates that in 330 
cells, the contribution of each individual viral protein to the inhibition of a signalling cascade during 331 
infection can only be assessed by studying very specific events (i.e. STING phosphorylation and 332 
STING dimerisation in this case). 333 
 334 
Multiple human viruses target STING function. For instance, the human cytomegalovirus protein 335 
UL82 binds to STING and prevents its translocation and activation (41); the Kaposi’s sarcoma-336 
associated herpesvirus (KSHV) protein vIRF1 prevents STING association with TBK-1 (42); the 337 
human papillomavirus and adenovirus suppress IFN-β production by targeting STING with their 338 
proteins E7 and E1A, respectively (43); whereas Dengue virus does so by cleaving STING via 339 
protein NS2B/3 (44, 45). Cleavage is unlikely to underlie the VACV mechanism since our data did 340 
not indicate a reduction in STING stability during infection. Other human viruses target cGAS, for 341 
example the KSHV proteins ORF52 and LANA (46, 47). At present our data demonstrate that 342 
VACV targets STING, but does not exclude that VACV may have evolved complementary 343 
mechanisms to interfere with cGAS/STING signalling such as masking the viral DNA with DNA-344 
binding proteins, targeting cGAS or enzymatically degrading cGAMP. The wide array of 345 
mechanisms that viruses employ to inhibit the cGAS-STING axis highlights the crucial role of this 346 
pathway in innate antiviral defence. In addition, the cGAS-STING pathway has a critical role in 347 
inflammatory diseases and in the induction of effective anti-cancer adaptive immunity (48-50). 348 
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STING activation is recurrently suppressed in a number of cancers and the level of STING 349 
signalling has been shown to correlate with the outcome of VACV or herpesvirus-based 350 
oncotherapy (51). The activation and regulation of DNA sensing during poxvirus infection provides 351 
a unique model to gain a better mechanistic understanding of DNA-mediated activation of immune 352 
responses and will inform in the rationale design of VACV-based therapies for vaccination and 353 
oncolytic treatment.  354 
 355 
MATERIALS AND METHODS 356 
Cells, reagents and viruses. HEK-293T, BS-C-1, RK-13 and BHK-21 cells were grown in 357 
Dulbecco Modified Eagle medium (DMEM, Life Technologies) supplemented with 10 % heat-358 
inactivated fetal calf serum (FCS, Seralab), 100 U/mL penicillin and 100 g/mL Streptomycin 359 
(Pen/Strep, Life Technologies). THP-1-IFIT-1-GLuc cells were a gift from Veit Hornung (University 360 
of Munchen, Germany). These cells had been modified to express GLuc under the control of the 361 
IFIT-1 promoter (26). THP-1-IFIT-1-GLuc cells were grown in Roswell Park Memorial Institute 362 
(RPMI) 1640 (Life Technologies) supplemented with 15 % FCS and Pen/Strep. PMA (Santa Cruz 363 
Biotechnology) was dissolved in DMSO at 10 mg/mL. HT-DNA (Sigma) was dissolved in water at 2 364 
mg/mL. 2’3’-cGAMP (Invivogen) was dissolved in water at 50 mg/mL. Sendai virus was a gift from 365 
Steve Goodbourn (St George’s University of London, United Kingdom). VACV strains MVA, vv811, 366 
COP and WR as well as CPXV strain Brighton Red were obtained from Geoffrey L. Smith 367 
(University of Cambridge, United Kingdom). ECTV strain Moscow was from Antonio Alcami 368 
(CBMSO, Spain). MVA was grown and titrated in CEF by conventional plaque assay. All other 369 
viruses were expanded in RK-13 or BS-C-1 cells and titrated in BS-C-1 cells. All viruses were 370 
purified through a 36 % sucrose cushion before use. 371 
 372 
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Reporter gene assays. THP-1-IFIT-1-GLuc cells were seeded in 96-well plates at a density of 5 × 373 
104 cells per well in the presence of PMA (50 ng/mL). 48 h later cells were infected in quadruplicate 374 
with the indicated viruses in RPMI 1640 supplemented with 2 % FCS at the indicated PFU per cell 375 
and the medium was collected at the indicated time p.i. When DNA stimulation was performed, 376 
PMA-differentiated cells were infected with the indicated viruses at 2 PFU/cell for 6 h and then 377 
transfected with HT-DNA at 0.5 g/mL for a further 16 h. Transfections were performed in 378 
OptiMEM (Life Technologies) in the presence of transfection reagent TransIT®-LT-1 (Mirus Bio) 379 
following the manufacturer’s recommendations. When cGAMP stimulation was performed, cells 380 
were infected as above and then exposed to 10 g/mL of cGAMP in the medium for a further 16 h. 381 
Luciferase activity was measured in a Clariostar plate reader (BMG Biotech) in the presence of 382 
coelenterazine (NanoLigh Technology) at 2 g/mL. Data were normalised to mock-infected 383 
samples and presented as a fold increase.  384 
 385 
Quantitative PCR. THP-1-IFIT-1-GLuc cells were seeded in 24-well plates at a density of 2 × 105 386 
cells per well in the presence of PMA (50 ng/mL). 48 h later cells were infected in triplicate with the 387 
indicated viruses in RPMI 1640 supplemented with 2 % FCS at the indicated PFU/cell for 16 h, or 388 
for 6 h and subsequently transfected with HT-DNA for a further 6 h as above. RNA was extracted 389 
using the Total RNA Purification Kit (Norgen Biotech) and transcribed into cDNA using Superscript 390 
III reverse transcriptase (Invitrogen) according to the manufacturer’s protocol. cDNA was diluted 391 
1:5 in water and was used as a template for real-time PCR using SYBR® Green PCR master mix 392 
(Applied Biosystems) in a LightCycler® 96 (Roche). Expression of each gene was normalised to an 393 
internal control (18S) and these values were then normalized to the non-stimulated mock-infected 394 
control cells to yield a fold induction. Primers used for CXCL10 detection were from (52). Primers 395 
for 18S detection were: Fwd 5’ GTAACCCGTTGAACCCCA 3’ and Rev 5’ 396 
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CCATCCAATCGGTAGTAGG; and for hIFN-β were: Fwd 5’ ACATCCCTGAGGAGATTAAGCA and 397 
Rev 5’ GCCAGGAGGTTCTCAACAATAG. 398 
 399 
ELISA. Cell culture supernatants from virus-infected THP-1 cells grown in 24-well plates were 400 
assayed for CXCL10 using Duoset ELISA reagents (R&D Biosystems) according to the 401 
manufacturer’s instructions. 402 
 403 
IFN bioassay. THP-1-IFIT1-GLuc cells were seeded in 96-well plates at a density of 5  104 cells 404 
per well in the presence of PMA (50 ng/mL). 48 h later cells were infected in quadruplicate with the 405 
indicated viruses in RPMI 1640 supplemented with 2 % FCS at the indicated PFU/cell. Medium 406 
was collected 24 h after and transferred to 96-well plate containing HEK293T cells previously 407 
transfected for 24 h with 70 ng/well of a reporter plasmid expressing Firefly luciferase under the 408 
control of ISRE (Promega) and 10 ng/well of a control plasmid expressing Renilla luciferase (RLuc, 409 
Promega) using polyethylenimine (PEI, Sigma) at a ratio 1:2 (g DNA:L PEI). Activation with 410 
recombinant hIFN-β at 25 ng/mL was also included as a control. Ten h after medium transfer, or 411 
hIFN-β activation, cells were lysed in Passive Lysis Buffer (Promega). FLuc and RLuc activity was 412 
measured in a Clariostar plate reader (BMG Biotech) and FLuc/RLuc ratios were calculated for 413 
each well. Data were normalised to mock-infected THP-1 samples and presented as fold increase. 414 
 415 
Generation of cell lines depleted for cGAS and STING. THP-1-IFIT-1-GLuc cells were first 416 
depleted for SAMHD1 using specific short hairpin sequences expressed from the HIV-1-based 417 
shRNA expression vector HIVSiren (53) and selected for hygromycin resistance (Invivogen, 200 418 
μg/ml), followed by depletion for STING using the above HIVSiren system, or cGAS using the MLV-419 
based shRNA expression vector pSIREN-RetroQ (Clontech), and selected for puromycin 420 
resistance (Merck Chemicals Ltd., 1 g/ml). Lentiviral particles were produced by transfection of 421 
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HEK293T cells with 1.5 g pHIVSIREN shRNA, 1 g p8.91 packaging plasmid (54) and 1 g 422 
vesicular stomatitis virus-G glycoprotein expressing plasmid pMDG (Genscript), or 1.5 g pSIREN-423 
RetroQ shRNA, 1 g pCMVi (MoMLV Gag‐Pol) and 1 g pMDG using Fugene 6 transfection 424 
reagent (Promega) according to the manufacturer’s instructions. Virus supernatants were 425 
harvested 48 h and 72 h post-transfection, pooled and used to transduce THP-1-IFIT-1-GLuc cells. 426 
SAMHD1 shRNA sequence: 5’ 427 
CGGGCCATCATCTTGGAATCCAAACTCGAGTTTGGATTCCAAGATGATGGCTTTTT 3’; STING 428 
shRNA sequence: 429 
5’GCCTGATAACCTGAGTATGTTCAAGAGACATACTCAGGTTATCAGGCTTTTTTACGCGT 3’; 430 
cGAS shRNA sequence: 5’ 431 
GGAAGGAAATGGTTTCCAATTCAAGAGATTGGAAACCATTTCCTTCCTTTTTTACGCGT 3’. 432 
 433 
SDS-PAGE and immunoblotting. Cells were lysed in radioimmunoprecipitation assay (RIPA) 434 
buffer supplemented with protease and phosphatase inhibitors (Roche) as well as 250 U/mL 435 
benzonase (Sigma). Lysates were rotated for 30 min at 4 C and subsequently denatured for 5 min 436 
at 95 C in the presence of loading buffer. Samples were resolved by SDS-PAGE and transferred 437 
to nitrocellulose membranes (GE Healthcare) using a Trans-Blot semi-dry transfer unit (Bio-Rad). 438 
Membranes were blocked in 0.1 % Tween PBS supplemented with 5 % skimmed milk (Sigma) and 439 
subjected to immunoblotting with the following primary antibodies at the indicated dilutions: 440 
phosphorylated STING Ser366 (Cell Signaling Technology, 1:1,000); STING (Cell Signaling 441 
Technology, 1:1,000); cGAS (Cell Signaling Technology, 1:1,000); IRF-3 (Abcam, 1:1,000); 442 
phosphorylated IRF-3 Ser386 (Abcam, 1:1,000); α-tubulin (Upstate Biotech, 1:10,000); and D8 (a 443 
gift from David Ulaeto [DSTL, United Kingdom]). Primary antibodies were detected using IRDye-444 
conjugated secondary antibodies in an Odyssey Infrared Imager (LI-COR Biosciences). Images 445 
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were analysed using Odyssey software and data were obtained after integration of at least 3 446 
independent experiments.  447 
 448 
STING dimerisation. Analysis of STING dimerisation was performed as described (29) with minor 449 
modifications. THP-1-IFIT-1-GLuc cells were seeded in 24-well plates at a density of 2  105 cells 450 
per well in the presence of PMA (50 ng/mL). After 48 h cells were infected with the indicated 451 
viruses in RPMI 1640 supplemented with 2 % FCS at the indicated PFU/cell. After 6 h the cells 452 
were transfected with 4 g/mL of HT-DNA for 4 h or exposed to 15 g/mL of cGAMP for 6 h and 453 
lysed as described above with the exception that lysates were mixed with NuPAGE LDS Sample 454 
buffer (Bio-Rad) and directly analysed by SDS-PAGE. 455 
 456 
Statistical analysis. Statistical significance was determined using an unpaired Student’s t-test with 457 
Welch’s correction where appropriate using the GraphPad Prism statistical software. 458 
 459 
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Figure legends 614 
FIG 1. MVA, but not COP or WR, activate IRF-3 and IFN production in PMA-differentiated THP-1 615 
cells. (A) PMA-differentiated THP-1-IFIT-1-GLuc cells were infected in quadruplicate with the 616 
indicated PFU/cell (in brackets) of MVA (black), COP (red) or WR (blue), and the medium was 617 
analysed for luciferase activity at the indicated times post-infection. Data were normalised to mock-618 
infected samples and presented as a fold increase. (B) BHK-21 cells were infected with the 619 
indicated PFU/cell of MVA, COP and WR. Cells were lysed in RIPA buffer and whole cell lysates 620 
were subjected to SDS-PAGE and immunoblotting for D8 and α-tubulin. (C, E) PMA-differentiated 621 
THP-1-IFIT-1-GLuc cells were infected in triplicate with 2 PFU/cell of MVA, COP or WR, and 16 h 622 
later mRNA expression levels of CXCL10 (C) and IFN-β (E) were assessed by qPCR. (D) Medium 623 
from cells infected as above with MVA, COP and WR were subjected to ELISA against CXCL10. 624 
(F) Medium from cells infected with 2, 1 and 0.5 PFU/cell of MVA or uninfected was transferred to 625 
HEK293T previously transfected with an ISRE reporter plasmid (ISRE-FLuc) and a renilla 626 
luciferase plasmid (RLuc). Plain medium (n.s.) or medium containing recombinant IFN-β (25 627 
ng/mL) were also used as controls. FLuc/RLuc ratios were normalised to the n.s. control and 628 
presented as a fold increase. In all assays, data are presented as mean ± SD and show one 629 
representative experiment of at least three. *p<0.05, **p<0.01 or ***p<0.001, unpaired Student’s t-630 
test.  631 
 632 
FIG 2. Activation of IRF-3 in THP-1 cells upon MVA infection requires STING and cGAS. (A, D) 633 
Whole cell lysates from THP-1 cells transduced with lentivirus expressing shRNA against STING 634 
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(shSTING) or control (shCtrl) (A), or against cGAS (shcGAS) or control (shCtrl) (D), were subjected 635 
to immunoblotting against α-tubulin and STING (A) or cGAS (D). (B, E) PMA-differentiated 636 
shSTING or shCtrl (B), or shcGAS or shCtrl cells (E), THP-1 cells were transfected with herring 637 
testes (HT)-DNA or infected with Sendai virus (SeV). After 16 h GLuc activity in the supernatant 638 
was measured and presented as a fold increase over non-stimulated conditions (n.s.). (C, F) PMA-639 
differentiated shSTING or shCtrl (C), or shcGAS or shCtrl (F), THP-1 cells were infected with 2, 1 640 
and 0.5 PFU/cell of MVA. After 24 h GLuc activity was measured and presented as a fold increase 641 
over a mock-infected condition. Data in all graphs are presented as mean ± SD and show one 642 
representative experiment of at least three, each performed in triplicate. **p<0.01 or ***p<0.001, 643 
unpaired Student’s t-test for the indicated comparisons. 644 
 645 
FIG 3. VACV strains COP and WR inhibit IRF-3 activation in response to exogenous DNA. PMA-646 
differentiated THP-1 cells were infected with 2 PFU/cell of MVA, COP or WR for 6 h and 647 
subsequently transfected with HT-DNA for a further 16 h. (A) GLuc activity was measured and 648 
presented as a fold increase over a mock-infected condition. (B-C) Cells were infected as in (A) 649 
and subsequently transfected with HT-DNA for a further 6 h. CXCL10 and IFN-β mRNA expression 650 
levels were assessed by qPCR. Data are presented as mean ± SD and show one representative 651 
experiment of at least three, each performed in triplicate. *p<0.05 or ***p<0.001, unpaired 652 
Student’s t-test comparing infections with mock. 653 
 654 
FIG 4. VACV strains COP and WR inhibit STING phosphorylation in response to DNA transfection. 655 
(A) PMA-differentiated THP-1 cells were infected with 2 PFU/cell of the indicated viruses for 6 h 656 
and subsequently transfected with HT-DNA (4 µg/mL) for the indicated time. Cells were lysed in 657 
RIPA buffer and whole cell lysates were subjected to SDS-PAGE and immunoblotting against the 658 
indicated proteins. (B) Ratio of phosphorylated/total STING for the indicated conditions integrating 659 
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quantitative data from 3 independent experiments. AU, arbitrary units. *p<0.05, unpaired Student’s 660 
t-test for the indicated comparison. 661 
 662 
FIG 5. VACV strains COP and WR inhibit STING dimerisation in response to DNA transfection. (A) 663 
PMA-differentiated THP-1 cells were infected with 2 PFU/cell of the indicated viruses for 6 h and 664 
subsequently transfected with HT-DNA for a further 4 h. Cells were lysed in RIPA buffer and whole 665 
cell lysates were subjected to SDS-PAGE and immunoblotting against the indicated proteins. (B) 666 
Ratio of dimeric/monomeric STING for the indicated conditions integrating quantitative data from 3 667 
independent experiments. AU, arbitrary units. *p<0.05, unpaired Student’s t-test for the indicated 668 
comparison. (C-D) PMA-differentiated THP-1 cells were infected with the indicated PFU/cell of WR 669 
(C) or COP (D) for 6 h and subsequently transfected with HT-DNA. Cell lysates were subjected to 670 
SDS-PAGE and immunoblotting as in (A).  671 
 672 
FIG 6. vv811 inhibits STING activation. (A) PMA-differentiated THP-1 cells were infected with 2 673 
PFU/cell of MVA, vv811 or COP for 6 h and subsequently transfected with HT-DNA for a further 16 674 
h. GLuc activity was measured and presented as a fold increase over mock-infected conditions. (B-675 
C) Cells were infected as in (A) and subsequently transfected with HT-DNA for a further 6 h. 676 
CXCL10 and IFN-β mRNA expression levels were assessed by qPCR. (D) PMA-differentiated 677 
THP-1 cells were infected with 2 PFU/cell of the indicated viruses for 6 h and subsequently 678 
transfected with HT-DNA (4 µg/mL) for a further 4 h. Cells were lysed in RIPA buffer and whole cell 679 
lysates were subjected to SDS-PAGE and immunoblotting against the indicated proteins. One 680 
representative experiment of at least 3 is shown. Data in all graphs are presented as mean ± SD, 681 
each performed in triplicate. *p<0.05, **p<0.01 or ***p<0.001, unpaired Student’s t-test comparing 682 
infection to mock. 683 
 684 
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FIG 7. VACV inhibits STING activation in response to cGAMP. (A) PMA-differentiated THP-1 cells 685 
were infected with 2 PFU/cell of the indicated viruses for 6 h and subsequently exposed to cGAMP 686 
a further 16 h. GLuc activity was measured and presented as a fold increase over mock-infected 687 
conditions. Data are presented as mean ± SD, each performed in triplicate. ***p<0.001, unpaired 688 
Student’s t-test comparing cGAMP-stimulated infections to cGAMP-stimulated mock. (B) PMA-689 
differentiated THP-1 cells were infected with 2 PFU/cell of the indicated viruses for 6 h and 690 
subsequently exposed to cGAMP (15 µg/mL) for a further 6 h. Cells were lysed in RIPA buffer and 691 
whole cell lysates were subjected to SDS-PAGE and immunoblotting against the indicated 692 
proteins. One representative experiment of at least 2 is shown.  693 
 694 
FIG 8. CPXV strain Brighton Red (BR) and ECTV strain Moscow (MOS) inhibit DNA-induced 695 
STING dimerisation. PMA-differentiated THP-1 cells were infected with 2 PFU/cell of the indicated 696 
viruses for 6 h and subsequently transfected with HT-DNA for a further 4 h. Cells were lysed in 697 
RIPA buffer and whole cell lysates were subjected to SDS-PAGE and immunoblotting against the 698 
indicated proteins. One representative experiment of at least 3 is shown. 699 
 700 
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